ACA
Apis Capital Advisors Portfolio holdings
AUM
$282M
This Quarter Return
+31.97%
1 Year Return
+109.09%
3 Year Return
+434.97%
5 Year Return
–
10 Year Return
–
AUM
$80.7M
AUM Growth
+$80.7M
(+8.4%)
Cap. Flow
-$11.8M
Cap. Flow
% of AUM
-14.61%
Top 10 Holdings %
Top 10 Hldgs %
77.08%
Holding
32
New
7
Increased
4
Reduced
18
Closed
2
Top Buys
| 1 |
KEM
KEMET Corporation
KEM
|
$2.21M |
| 2 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$1.43M |
| 3 |
DERM
Dermira, Inc.
DERM
|
$1.22M |
| 4 |
CoreCard
CCRD
|
$639K |
| 5 |
Vicor
VICR
|
$620K |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$3.9M |
| 2 |
NovoCure
NVCR
|
$2.68M |
| 3 |
Silicon Motion
SIMO
|
$2.07M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$1.65M |
| 5 |
I
INTELSAT S. A.
I
|
$1.57M |
Sector Composition
| 1 | Healthcare | 59.7% |
| 2 | Technology | 9.89% |
| 3 | Consumer Discretionary | 7.15% |
| 4 | Energy | 6.38% |
| 5 | Industrials | 3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
1
Amarin Corp
AMRN
$311M
| $23.4M | 28.21% | 1,126,700 -35,300 | -3% | -$733K |
|
|
ARRY
2
DELISTED
Array Biopharma Inc
ARRY
| $8.05M | 9.7% | 330,000 -160,000 | -33% | -$3.9M |
|
|
ZGNX
3
DELISTED
Zogenix, Inc.
ZGNX
| $6.79M | 8.19% | 123,500 -30,000 | -20% | -$1.65M |
|
|
KEM
4
DELISTED
KEMET Corporation
KEM
| $5.77M | 6.96% | 340,000 +130,000 | +62% | +$2.21M |
|
5
Golar LNG
GLNG
$4.48B
| $5.15M | 6.21% | 244,000 -70,000 | -22% | -$1.48M |
|
|
6
Vicor
VICR
$2.3B
| $3.72M | 4.49% | 120,000 +20,000 | +20% | +$620K |
|
|
CYBE
7
DELISTED
Cyberoptics Corp
CYBE
| $3.07M | 3.7% | 179,461 -40,539 | -18% | -$693K |
|
|
BSTC
8
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $2.24M | 2.71% | 36,000 -4,000 | -10% | -$249K |
|
|
9
Silicon Motion
SIMO
$2.71B
| $2.1M | 2.53% | 52,900 -52,100 | -50% | -$2.07M |
|
10
Green Dot
GDOT
$771M
| $1.94M | 2.34% | 32,000 -8,000 | -20% | -$485K |
|
11
Viking Therapeutics
VKTX
$3.04B
| $1.49M | 1.8% | 150,000 +30,000 | +25% | +$298K |
|
|
CBAY
12
DELISTED
Cymabay Therapeutics
CBAY
| $1.46M | 1.76% | 110,000 -50,000 | -31% | -$664K |
|
13
Verisk Analytics
VRSK
$37.5B
| $1.43M | 1.72% | 10,750 -1,250 | -10% | -$166K |
|
|
AERI
14
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.43M | 1.72% | +30,000 | New | +$1.43M |
|
15
Match Group
MTCH
$8.98B
| $1.42M | 1.71% | 25,000 -10,000 | -29% | -$566K |
|
|
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.32M | 1.6% | 25,000 -2,000 | -7% | -$106K |
|
|
17
NovoCure
NVCR
$1.38B
| $1.22M | 1.48% | 25,400 -55,700 | -69% | -$2.68M |
|
|
DERM
18
DELISTED
Dermira, Inc.
DERM
| $1.22M | 1.47% | +90,000 | New | +$1.22M |
|
19
Sarepta Therapeutics
SRPT
$1.78B
| $1.19M | 1.44% | 10,000 -2,000 | -17% | -$238K |
|
|
I
20
DELISTED
INTELSAT S. A.
I
| $1.1M | 1.32% | 70,000 -100,000 | -59% | -$1.57M |
|
21
LiqTech
LIQT
$18.8M
| $989K | 1.19% | 460,000 +14,000 | +3% | +$30.1K |
|
|
DSPG
22
DELISTED
DSP Group Inc
DSPG
| $982K | 1.18% | 69,800 -30,200 | -30% | -$425K |
|
23
Alpha Metallurgical Resources
AMR
$1.95B
| $927K | 1.12% | 16,000 | – | – |
|
|
24
CoreCard
CCRD
$216M
| $639K | 0.77% | +20,000 | New | +$639K |
|
25
Forte Biosciences
FBRX
$137M
| $537K | 0.65% | 49,374 -626 | -1% | -$6.81K |
|